Mutational and evolutionary impact of mitochondrial dysfunction

线粒体功能障碍的突变和进化影响

基本信息

  • 批准号:
    8448696
  • 负责人:
  • 金额:
    $ 27.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-10 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The main objective of the proposed research project is to provide knowledge on the mutational and evolutionary consequences of reactive oxygen species (ROS) that result from mitochondrial dysfunction. ROS are central players in a variety of human disorders and the aging process, but also play important protective roles in innate immunity against parasites. The main objective will be achieved using the model nematode Caenorhabditis elegans and its sister species C. briggsae. The first specific aim is to determine the impact of ROS on genome-wide germline mutation processes. This aim will be accomplished by first creating mutation-accumulation (MA) lines from C. elegans genetic mutants that experience higher or lower levels of ROS as compared to wild-type, and from C. briggsae strains that experience varying levels of ROS due variation in naturally-occurring mitochondrial genome deletions. The nuclear genomes of the resultant MA lines will be comprehensively analyzed for mutation using Solexa high-throughput DNA sequencing technology. The achievement of this aim will confirm or deny the widely held, but unproven hypothesis that ROS of mitochondrial origin cause elevated mutation rates in the nuclear genome. The second specific aim is to characterize the somatic mutation effects of ROS as a function of age. A simple yet powerful somatic mutation reporter transgene system will be employed to examine the mosaic somatic mutation process in the same C. elegans genetic backgrounds used for the first aim. Achievement of the second aim will provide essential knowledge on the role of ROS in somatic mutation accumulation, and novel insights into the extent to which germline and somatic mutation processes are coupled. The third specific aim is to identify the evolutionary causes of naturally- occurring mitochondrial genome deletions in C. briggsae. This aim will be accomplished by testing two opposing hypotheses: a first non-adaptive hypothesis that the deletions passively evolved due to weak natural selection associated with evolution in small populations, and a second adaptive hypothesis that ROS resulting from the deletions play a functional role in protecting nematodes against intracellular parasite infections. The first hypothesis will be tested using laboratory comparative population size studies involving C. briggsae of varying mitochondrial genome deletion levels; the second hypothesis will be tested using infection and competition assays involving Nematocida sp. 1, a newly discovered microsporidia parasite that infects C. briggsae in nature. Correlations between deletion levels and infection status will also be tested for in C. briggsae natural isolates. Achievement of the three aims will provide unprecedented knowledge on the effects of ROS on nuclear genome mutation processes, and the potential of a new paradigm for understanding the interplay between selection against the highly negative effects of ROS, and positive selection for ROS-induced resistance to parasites.
描述(由申请人提供): 拟议研究项目的主要目标是提供有关线粒体功能障碍导致的活性氧(ROS)突变和进化后果的知识。ROS是多种人类疾病和衰老过程中的核心参与者,但也在对抗寄生虫的先天免疫中发挥重要的保护作用。主要目的将使用模式线虫秀丽隐杆线虫及其姊妹种C.布里格塞第一个具体目标是确定ROS对全基因组种系突变过程的影响。这一目标将通过首先从C.与野生型相比经历更高或更低水平的ROS的秀丽隐杆线虫遗传突变体,以及来自C. Briggsae菌株由于天然存在的线粒体基因组缺失的变异而经历不同水平的ROS。将使用Solexa高通量DNA测序技术全面分析所得MA系的核基因组的突变。这一目标的实现将证实或否认广泛持有的,但未经证实的假设,即线粒体起源的ROS导致核基因组突变率升高。第二个具体目标是表征ROS作为年龄的函数的体细胞突变效应。我们将利用一个简单而有效的体细胞突变报告转基因系统来研究同一个C. elegans遗传背景用于第一个目的。第二个目标的实现将提供必要的知识的作用,活性氧在体细胞突变的积累,和新的见解生殖细胞和体细胞突变过程耦合的程度。第三个具体的目标是确定自然发生的线粒体基因组缺失的进化原因,在C。布里格塞这一目标将通过测试两个相反的假设来实现:第一个非适应性假设,即由于与小种群进化相关的弱自然选择,缺失被动进化,第二个适应性假设,即缺失产生的ROS在保护线虫免受细胞内寄生虫感染中发挥功能性作用。第一个假设将使用实验室比较人口规模的研究,包括C。第二种假设将使用涉及杀线虫属1的感染和竞争测定来检验,杀线虫属1是一种新发现的感染C.自然界中的布里格塞缺失水平和感染状态之间的相关性也将在C中进行测试。Briggsae天然分离物。这三个目标的实现将提供前所未有的知识,ROS对核基因组突变过程的影响,并了解一个新的范例之间的相互作用,对ROS的高度负面影响的选择,和积极的选择ROS诱导的抗寄生虫的潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DEE DENVER其他文献

DEE DENVER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DEE DENVER', 18)}}的其他基金

Mutational and evolutionary impact of mitochondrial dysfunction
线粒体功能障碍的突变和进化影响
  • 批准号:
    8056586
  • 财政年份:
    2010
  • 资助金额:
    $ 27.29万
  • 项目类别:
Mutational and evolutionary impact of mitochondrial dysfunction
线粒体功能障碍的突变和进化影响
  • 批准号:
    8245878
  • 财政年份:
    2010
  • 资助金额:
    $ 27.29万
  • 项目类别:
Mutational and evolutionary impact of mitochondrial dysfunction
线粒体功能障碍的突变和进化影响
  • 批准号:
    8641387
  • 财政年份:
    2010
  • 资助金额:
    $ 27.29万
  • 项目类别:
Mutational and evolutionary impact of mitochondrial dysfunction
线粒体功能障碍的突变和进化影响
  • 批准号:
    7785123
  • 财政年份:
    2010
  • 资助金额:
    $ 27.29万
  • 项目类别:
Mutation spectra in DNA repair-deficient backgrounds
DNA 修复缺陷背景中的突变谱
  • 批准号:
    6740897
  • 财政年份:
    2002
  • 资助金额:
    $ 27.29万
  • 项目类别:
Mutation spectra in DNA repair-deficient backgrounds
DNA 修复缺陷背景中的突变谱
  • 批准号:
    6640573
  • 财政年份:
    2002
  • 资助金额:
    $ 27.29万
  • 项目类别:
Mutation spectra in DNA repair-deficient backgrounds
DNA 修复缺陷背景中的突变谱
  • 批准号:
    6552470
  • 财政年份:
    2002
  • 资助金额:
    $ 27.29万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了